Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226. 1995

M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
Department of Pharma Research, Dr. Karl Thomae GmbH, Biberach, Germany.

The binding of tritium-labelled BIBP3226, N2-(diphenylacetyl)-N-[(4-hydroxy-phenyl)methyl]-D-arginine amide, to human neuroblastoma SK-N-MC cells was investigated. [3H]BIBP3226 reversibly binds to neuropeptide Y receptors of the Y1 subtype expressed in SK-N-MC cells with a KD of 2.1 +/- 0.3 nM (mean +/- S.E.M., n = 3) and a Bmax of 58,400 +/- 1100 sites/cell. Non-specific binding did not exceed 30% of the total radioactivity bound at KD. In competition experiments [3H]BIBP3226 is concentration-dependently displaced by neuropeptide Y and its peptide analogues with an affinity pattern neuropeptide Y = [Leu31, Pro34]neuropeptide Y >> neuropeptide Y-(18-36). This rank order of potencies is consistent with the interaction of [3H]BIBP3226 with neuropeptide Y receptors of the Y1 subtype. Therefore, [3H]BIBP3226 can be used as selective ligand to study neuropeptide Y Y1 receptors.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D017476 Receptors, Neuropeptide Y Cell surface proteins that bind neuropeptide Y with high affinity and trigger intracellular changes which influence the behavior of cells. Neuropeptide Y Receptors,Neuropeptide Y Receptor,Receptor, Neuropeptide Y

Related Publications

M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
January 1998, Journal of receptor and signal transduction research,
M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
February 1998, The European journal of neuroscience,
M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
December 1994, European journal of pharmacology,
M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
July 1997, European journal of pharmacology,
M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
July 1991, Naunyn-Schmiedeberg's archives of pharmacology,
M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
October 1995, The Journal of pharmacology and experimental therapeutics,
M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
May 1999, Progress in neuro-psychopharmacology & biological psychiatry,
M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
September 1992, Biochemical and biophysical research communications,
M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
November 1990, Neuroscience letters,
M Entzeroth, and H Braunger, and W Eberlein, and W Engel, and K Rudolf, and W Wienen, and H A Wieland, and K D Willim, and H N Doods
March 1996, Neuroreport,
Copied contents to your clipboard!